🔗 Share this article

Treasury head Rachel Reeves has stated she is preparing "focused steps to address household expense challenges" in next month's financial statement.

In comments to media outlets, she noted that reducing price rises is a collective responsibility of both the administration and the Bank of England.

The United Kingdom's inflation rate is forecast to be the most elevated among the G7 industrialized countries this year and the following year.

Possible Utility Bill Interventions

It is understood the administration could intervene to bring down energy bills, such as by cutting the present 5% level of value-added tax applied on energy supplies.

An additional option is to reduce some of the policy costs presently included in household expenses.

Budgetary Limitations and Expert Predictions

The administration will receive the latest report from the official forecaster, the OBR, on the start of the week, which will reveal how much space there is for these actions.

The expectation from the majority of experts is that Reeves will have to declare higher taxes or expenditure reductions in order to meet her self-imposed borrowing rules.

Previously on the same day, analysis suggested there was a £22bn deficit for the chancellor to address, which is at the lower end of forecasts.

"It is a shared task between the Bank of England and the government to continue tackling some of the drivers of price increases," Reeves told the BBC in Washington, at the conferences of the International Monetary Fund and global financial institution.

Tax Commitments and Global Concerns

While much of the focus has been on likely tax increases, the Treasury chief said the latest figures from the OBR had not changed her vow to manifesto promises not to increase rates on earnings tax, VAT or social security contributions.

She attributed an "uncertain world" with increasing international and commercial concerns for the fiscal revenue measures, likely to be targeted on those "wealthiest."

International Economic Tensions

Commenting on concerns about the UK's economic relations with the Asian nation she said: "Our security interests always are paramount."

Last week's declaration by Chinese authorities to strengthen export controls on rare earths and other resources that are essential for advanced tech manufacturing led American leader the US President to suggest an extra 100% tariff on goods from the Asian country, raising the prospect of an all-out trade war between the two economic giants.

The American finance chief labeled China's decision "commercial pressure" and "a global supply chain control attempt."

Inquired about considering the US offer to join its battle with the Asian nation, the Chancellor said she was "deeply worried" by Chinese measures and called on the Beijing authorities "to avoid restrictions and limit trade."

She said the move was "harmful for the world economy and causes further obstacles."

"In my view there are sectors where we should challenge Chinese policies, but there are also important prospects to trade with Chinese markets, including financial services and other areas of the economic system. We've got to get that balance correct."

The Treasury chief also affirmed she was working with international partners "on our own essential resources approach, so that we are more independent."

NHS Drug Costs and Funding

Reeves also admitted that the price the NHS pays for drugs could go up as a result of current negotiations with the US government and its drugs companies, in exchange for lower tariffs and capital.

Some of the world's largest pharmaceutical manufacturers have said in recent statements that they are either delaying or canceling investments in the United Kingdom, with several attributing the insufficient payments they are receiving.

Recently, the Science Minister said the price the NHS pays for medicines would have to increase to stop businesses and pharmaceutical investment departing from the United Kingdom.

Reeves stated to the BBC: "We have seen because of the cost structure, that medical research, recent pharmaceuticals have not been available in the UK in the manner that they are in other European countries."

"Our aim is to ensure that individuals getting treatment from the National Health Service are can obtain the top life-saving drugs in the globe. And so we are examining this situation, and... looking to secure increased investment into the UK."